BioCentury
ARTICLE | Company News

City of Hope, Novonco Therapeutics deal

August 24, 2015 7:00 AM UTC

City of Hope granted Novonco exclusive rights to COH29. The small molecule ribonucleotide reductase inhibitor is in preclinical testing to treat cancer. Novonco plans to start U.S. clinical trials t...